The Testosterone Replacement Lawyers at Parilman & Associates Alert Public to Request to FDA by Public Citizen to Place Warnings on Labels of Testosterone Drugs

Share Article

The testosterone replacement therapy attorneys at Parilman & Associates, whose Web site URL can be found at http://www.parilmanlaw.com, represent clients who believe that they have been harmed by medical products including medications. The firm hereby alerts the public to a request issued by Public Citizen, a consumer advocacy group, to the FDA demanding that specific warnings be placed on labels of testosterone replacement therapy medication.

The testosterone therapy lawyers at Parilman & Associates have been handling inquiries from prospective clients regarding the possibility that they were harmed as a result of undergoing testosterone replacement therapy. The firm represents clients around the United States who believe that they were injured by medications, and the attorneys at Parilman & Associates would like to alert the public of a request made by Public Citizen, a consumer advocacy group, to the FDA stating that warnings on labels of testosterone replacement therapy medications should be required.

The request, a copy of which can be found here, was issued on February 25, 2014 and it was sent to the Division of Dockets Management of the FDA. A report describing the release of this letter that was released by CBS News that is also dated February 25, 2014 can be found here. The report is entitled, “Group Asks FDA for black box warning on testosterone products due to heart risks.” Public Citizen specifically requested that the FDA take precautionary steps that include: (1) adding a black box warning regarding the possibility that using testosterone replacement medication could increase the risks of heart attacks and strokes; (2) asking the manufacturers of these medications to send “Dear Doctor” letters warning physicians of these potential risks; and (3) delaying the FDA’s decision date on approving a new testosterone replacement therapy medication. The CBS News story linked above also describes these requests.

The statement went on to include the following language:
“Despite increasing evidence of significant cardiovascular risk from an analysis of 27 randomized clinical trials and, most recently, from a large observational study involving 45 times more testosterone-exposed men than the largest previous study, warnings of testosterone-induced cardiovascular risk are dangerously absent from the current FDA-approved labeling for all of these products.”

The testosterone replacement therapy lawyers at Parilman & Associates would like for the public to be aware of the fact that such requests are being made. We would also like to commend Public Citizen for voicing its opinion in a public manner and urging the FDA to take action so that any potential dangers with regards to using these medications can be uncovered and shared with the public as soon as possible.

About Parilman & Associates
Parilman & Associates is a nationwide law firm that represents individuals and classes of consumers who have been injured by defective products. These products include defective medical devices and defective medications. The firm also represents clients who have been injured by exposure to asbestos and those who have been wrongfully harmed in different types of accidents. The firm’s Facebook profile can be found at https://www.facebook.com/parilmaninjurylawyers. The firm can also be reached by phone at 800-800-DRUG.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joshua Parilman
Visit website